MedTrace Logo

Tranexamic Acid in Pregnancies With Vaginal Bleeding

NCT03632824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2020-01-22

No results posted yet for this study

Summary

Tranexamic acid has been proposed and used for prevention and management of antepartum and postpartum hemorrhage.

Conditions

  • Vaginal Bleeding During Pregnancy

Interventions

DRUG

Tranexamic Acid

One gram( 2 ampules ) of tranexamic acid was received by the participant intravenously twice daily for 48 hours followed by 500 mg tranexamic acid tablet three times daily for 5 days . follow up of the patient was done by recurrence of the bleeding latter on during pregnancy . the course of treatment was repeated again .

Sponsors & Collaborators

  • Hawler Medical University

    lead OTHER

Principal Investigators

  • Ariana K. Jawad · Hawler Medical University, college of Medicine, department of Obstetrics and Gynecology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2020-01-15
Completion
2020-01-18

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632824 on ClinicalTrials.gov